Providing "scientific advice" to pharma industry undermines the independence of regulatory authorities
'Investor-to-state dispute settlement' in EU-US trade deal threatens access to affordable medicines
EMA's new policy on access to clinical data: About to privatise pharmaceutical knowledge? The proof will be in the pudding
Backpedalling on EMA's "proactive publication of clinical-data" draft policy: Was it all just a window-dressing exercise? Who or what is the EMA afraid of?
EU Regulation on clinical trials: An urgent call for support to clinical data transparency